Details
Stereochemistry | ABSOLUTE |
Molecular Formula | 2C5H6NO3.Ca |
Molecular Weight | 296.29 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[Ca++].[O-]C(=O)[C@@H]1CCC(=O)N1.[O-]C(=O)[C@@H]2CCC(=O)N2
InChI
InChIKey=YQFZERWESBDNRJ-QHTZZOMLSA-L
InChI=1S/2C5H7NO3.Ca/c2*7-4-2-1-3(6-4)5(8)9;/h2*3H,1-2H2,(H,6,7)(H,8,9);/q;;+2/p-2/t2*3-;/m00./s1
Molecular Formula | Ca |
Molecular Weight | 40.078 |
Charge | 2 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | C5H6NO3 |
Molecular Weight | 128.106 |
Charge | -1 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
In calcium pidolate, the calcium ion is bound to two molecules of pyrrolidone carboxylic acid that act as protein supports. None of the calcium salts currently employed therapeutically (chloride, carbonate, lactate, gluconate, glucoheptonate, gluconolactate, gluconogalactogluconate, lactobionate, etc.) contain a protein support. Calcium pidolate is the only drug in which the calcium is transported by a protein substrate that is directly assimilable and specific to the body's bony matrix. Calcium pidolate can help the body's own calcium in performing its two primary roles: in any adverse changes in bony tissue during its growth, during bone ageing or traumatic bone lesions, Calcium pidolate can provide both a protein framework and a mineral source, as regards various metabolic functions of calcium, calcium pidolate have demonstrated that the substance is perfectly absorbed and distributed throughout various tissues and that it stimulates numerous hormonal and metabolic activities. In the treatment of various forms of osteoporosis with calcium pidolate, it is used curatively.
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:04:06 GMT 2025
by
admin
on
Mon Mar 31 18:04:06 GMT 2025
|
Record UNII |
7Y2LVU5EKK
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
87393
Created by
admin on Mon Mar 31 18:04:06 GMT 2025 , Edited by admin on Mon Mar 31 18:04:06 GMT 2025
|
PRIMARY | RxNorm | ||
|
7Y2LVU5EKK
Created by
admin on Mon Mar 31 18:04:06 GMT 2025 , Edited by admin on Mon Mar 31 18:04:06 GMT 2025
|
PRIMARY | |||
|
7Y2LVU5EKK
Created by
admin on Mon Mar 31 18:04:06 GMT 2025 , Edited by admin on Mon Mar 31 18:04:06 GMT 2025
|
PRIMARY | |||
|
DTXSID501019893
Created by
admin on Mon Mar 31 18:04:06 GMT 2025 , Edited by admin on Mon Mar 31 18:04:06 GMT 2025
|
PRIMARY | |||
|
100000090379
Created by
admin on Mon Mar 31 18:04:06 GMT 2025 , Edited by admin on Mon Mar 31 18:04:06 GMT 2025
|
PRIMARY | |||
|
C092985
Created by
admin on Mon Mar 31 18:04:06 GMT 2025 , Edited by admin on Mon Mar 31 18:04:06 GMT 2025
|
PRIMARY | |||
|
250-602-4
Created by
admin on Mon Mar 31 18:04:06 GMT 2025 , Edited by admin on Mon Mar 31 18:04:06 GMT 2025
|
PRIMARY | |||
|
31377-05-6
Created by
admin on Mon Mar 31 18:04:06 GMT 2025 , Edited by admin on Mon Mar 31 18:04:06 GMT 2025
|
PRIMARY | |||
|
14559044
Created by
admin on Mon Mar 31 18:04:06 GMT 2025 , Edited by admin on Mon Mar 31 18:04:06 GMT 2025
|
PRIMARY | |||
|
SUB13194MIG
Created by
admin on Mon Mar 31 18:04:06 GMT 2025 , Edited by admin on Mon Mar 31 18:04:06 GMT 2025
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE |